Copyright © 2019 EnBiotix, Inc.. All Rights Reserved

Tunable Target Degradation Platform


Transformational Target Validation through Tunable Degradation

EnBiotix’s novel and proprietary Tunable Target Degradation (TTD) platform allows for unprecedented experimental target validation, and represents a significant advance over genetic-knockouts(limited utility in studying essential genes due to their binary outcome) or anti-sense silencing (effects on distal gene expression).

TTD enables validation of essential as well as non-essential targets, and only modifies functions directly affected by the target protein.  Based on a 2014 Collins publication in Nature Biotechnology, the inducible protease TTD platform:

  • Yields functional assessments of targets, pathways, MOAs in vitro and in vivo
  • Determines the level of inhibition required to achieve a desired phenotype
  • Assesses target vulnerability without a chemical inhibitor

Key developments:

  • A library of TTD-modified coli essential genes has been constructed and characterized
  • Library can be used to identify highest value candidate targets for novel anti-infectives
  • Broadly applicable to other bacterial species and strains

Bacterial strains with TTD-modified proteins show proof-of-concept of hypersensitivity to antibiotic treatment. Proof-of-concept also demonstrated using TTD for precise control of steady-state levels of a target to determine the phenotype associated with that level of target inhibition